A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma

(2010) J. A. Richter-Larrea et al.   BLOOD

Transcriptional role of cyclin D1 in development revealed by a genetic–proteomic screen

(2010) Frédéric Bienvenu et al.   NATURE

How I treat mantle cell lymphoma

(2009) M. Ghielmini et al.   BLOOD

Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?

(2009) Martin Dreyling et al.   CURRENT OPINION IN ONCOLOGY

Cell cycle kinases as therapeutic targets for cancer

(2009) Silvia Lapenna et al.   NATURE REVIEWS DRUG DISCOVERY

Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2

(2008) M Klier et al.   LEUKEMIA

Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators

(2008) G Roué et al.   ONCOGENE

Cyclin D1 in low-dose radiation-induced adaptive resistance

(2008) K M Ahmed et al.   ONCOGENE